C71T
CANCELLED SECTION 71
05/15/2026
Back to search
Official data from USPTO
ESAPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
06/09/2026
Trademark type
Word
Nice classes
3, 5
Filing date
12/19/2018
Registration date
10/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/15/2026
Last transaction
06/09/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
IT
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ESAPHARMA S.P.A.
ESAPHARMA S.R.L.
Representatives
Jamie E. Sternberg Cantor Colburn LLP
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Creams and lotions for the facehands and body; beauty creams; creamsoilslotionstopical skin sprayspencils and non-medicated lip balms for cosmetic purposes; cosmetic body creams; body emulsions for cosmetic purposes; body lotions for cosmetic purposes; body milks for cosmetic use; cosmetics; bathing lotions for cosmetic purposes; body sprays for cosmetic purposes; cosmetic preparations; beauty preparationscosmetics; cosmetic oils for the skin; cosmetic preparations for body care; cosmetics for use on the skin; antiperspirant soap; deodorant soap; shaving soap; deodorants for personal use; perfumes; air fragrancing preparations; bath preparationsnot for medical purposes; tissues impregnated with make-up removing preparations
Class 5
Medicinal skin care creams for treating dermatological conditionstreating fungusfor skin treatment; hydrocortisone creams; cortisone-based dermatological creams and gels; medicated gelscreams and solutions for dermatological use; acne medication
Publications
History of USPTO decisions and trademark events.
30 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/12/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/29/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/06/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/13/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/25/2020
FIMP
FINAL DISPOSITION PROCESSED
02/25/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/29/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/16/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2019
PUBO
PUBLISHED FOR OPPOSITION
08/13/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/31/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/31/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2019
ALIE
ASSIGNED TO LIE
07/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/10/2019
RFNP
REFUSAL PROCESSED BY IB
03/22/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/07/2019
RFRR
REFUSAL PROCESSED BY MPU
03/07/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/28/2019
CNRT
NON-FINAL ACTION WRITTEN
02/27/2019
DOCK
ASSIGNED TO EXAMINER
02/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
02/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/04/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/31/2019
Continuous trademark protection
Get notified about every new filing that threatens ESAPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.